Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ScottsMiracle-Gro’s 2025 Corporate Responsibility Report highlights advancements in recyclable packaging, waste reduction and water conservation
From Scotts Miracle-Gro Company (The)
Via GlobeNewswire
Tickers SMG
IREN Purchases 4.2k NVIDIA Blackwell GPUs & Secures Financing - AI Cloud Expanded to 8.5k GPUs
From IREN
Via GlobeNewswire
Tickers IREN
From Cloud Nine to Toy Shelves: L.O.L. Surprise! x Care Bears Collab Brings Six Limited-Edition Dolls to Fans Worldwide
From MGA Entertainment
Via GlobeNewswire
New Report Reveals 85% of Health Plans Have Yet to Centralize Their Data Across Systems
From Arcadia
Via GlobeNewswire
Synaptics To Participate at Upcoming Investor Conferences on Thursday, August 28, 2025 and Thursday, September 4, 2025
From Synaptics Incorporated
Via GlobeNewswire
Tickers SYNA
Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
From Incyclix Bio
Via GlobeNewswire
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
From Beam Therapeutics
Via GlobeNewswire
Tickers BEAM
Blockmate investee Hivello recognized in Forbes as leading DePIN innovator
From Blockmate Ventures Inc.
Via GlobeNewswire
Tickers MATEF TSX-V:MATE
EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
From EDAP TMS S.A.
Via GlobeNewswire
Tickers EDAP
Jade Biosciences to Participate in Upcoming Conferences
From Jade Biosciences
Via GlobeNewswire
Tickers JBIO
MEXC Launches Airdrop+ Event with 75,000 USDT Prize Pool to Celebrate Listing of Camp Network (CAMP)
From MEXC
Via GlobeNewswire
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
From Biogen Inc.
Via GlobeNewswire
Tickers BIIB STOK
New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
From Castle Biosciences, Inc.
Via GlobeNewswire
Tickers CSTL
Climb Bio to Present at Upcoming September 2025 Investor Conferences
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Edustaff Establishes First Alabama Partnership with Anniston City Schools
From Edustaff
Via GlobeNewswire
COFECE Approves Pan American Silver's Arrangement with MAG Silver
From MAG Silver Corp.
Via GlobeNewswire
Tickers PAAS TSX:MAG TSX:PAAS
Golf Superstore Uses Descartes Sellercloud™ to Unify Omnichannel Operations
From The Descartes Systems Group Inc
Via GlobeNewswire
Tickers DSGX TSX:DSG
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
From Axogen, Inc.
Via GlobeNewswire
Tickers AXGN
Abercrombie & Fitch and NFL Announce Official Fashion Partnership
From Abercrombie & Fitch Management Co.
Via GlobeNewswire
Tickers ANF
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
From Royalty Pharma plc
Via GlobeNewswire
Tickers RPRX
Crafting Seamless Notifications: How EngageLab’s Chrome Extension WebPush Is Transforming User Engagement and Extension Efficiency
From EngageLab
Via GlobeNewswire
Tickers JG
Pick and Place Machine Innovator - NECTEC Launches Next-Gen SMT Line Solution With LED and X-ray Technology
From NECTEC PTE. LTD.
Via GlobeNewswire
Server PSU Supplier Linklieo Expands Global CRPS and Common Redundant Power Solutions
From Linklieo Technology Co Limited
Via GlobeNewswire
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
From Oculis Holding AG
Via GlobeNewswire
Tickers OCS
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
From Vaxxas Pty Ltd
Via GlobeNewswire
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
From Biogen Inc.
Via GlobeNewswire
Tickers BIIB
Aegon implements increase in share buyback program
From Aegon Ltd.
Via GlobeNewswire
Equinor ASA: Announcement of cash dividend of NOK 3.7740 per share for first quarter 2025
From Equinor ASA
Via GlobeNewswire
argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
From argenx SE
Via GlobeNewswire
Tickers ARGX
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
From VALNEVA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.